State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Mol Cancer. 2010 Jan 10;9:4. doi: 10.1186/1476-4598-9-4.
Increasing amounts of evidence indicate that tumor infiltrating lymphocytes (TIL) are correlated with the prognosis of cancer patients. This study focuses on the association between the densities of tumor infiltrating cytotoxic T lymphocytes (CTL), activated CTL, regulatory T lymphocytes (Treg) and Th17 lymphocytes, and the prognosis and clinicopathological features of nasopharyngeal carcinoma (NPC) patients.
Double immunohistochemical staining was performed in 106 biopsy specimens from newly diagnosed NPC patients. Prognostic values of infiltrating lymphocyte densities were evaluated by Kaplan-Meier analysis and Cox regression. The density of CD8+ TIL was positively correlated with lymph node metastasis, while the density of Foxp3+ TIL was negatively associated with T stage (P < 0.05). For survival evaluation, the density of Foxp3+ TIL or Foxp3+ TIL combined with GrB+ TIL together was associated with better overall survival (OS) and progression-free survival (PFS) (P < 0.01) in all patients and in the patients with late-stage diseases (Stages III and IV, P < 0.01). Meanwhile a low density of CD8+TIL or high ratio of FOXP3+TIL to CD8+TIL was correlated with better PFS in early stage patients (Stages I and II, P < 0.05). No significant association was found between IL-17+ TIL and clinicopathological characteristic or survival of NPC patients.
Our study identifies for the first time the tumor infiltrating Foxp3+ TIL as an independent favorable factor in the prognosis of NPC patients, especially for the patients with late-stage diseases.
越来越多的证据表明肿瘤浸润淋巴细胞(TIL)与癌症患者的预后相关。本研究重点关注肿瘤浸润细胞毒性 T 淋巴细胞(CTL)、活化 CTL、调节性 T 淋巴细胞(Treg)和 Th17 淋巴细胞的密度与鼻咽癌(NPC)患者的预后和临床病理特征之间的关系。
对 106 例新诊断的 NPC 患者的活检标本进行了双重免疫组织化学染色。通过 Kaplan-Meier 分析和 Cox 回归评估浸润淋巴细胞密度的预后价值。CD8+TIL 的密度与淋巴结转移呈正相关,而 Foxp3+TIL 的密度与 T 分期呈负相关(P<0.05)。在生存评估方面,Foxp3+TIL 或 Foxp3+TIL 与 GrB+TIL 联合的密度与所有患者以及晚期疾病(III 期和 IV 期)患者的总生存(OS)和无进展生存(PFS)更好相关(P<0.01)。同时,CD8+TIL 密度低或 FOXP3+TIL 与 CD8+TIL 的比值高与早期患者的 PFS 更好相关(I 期和 II 期,P<0.05)。IL-17+TIL 与 NPC 患者的临床病理特征或生存之间没有显著关联。
本研究首次确定肿瘤浸润性 Foxp3+TIL 是 NPC 患者预后的独立有利因素,特别是对晚期疾病患者。